Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Poliomyelitis - Overview
Poliomyelitis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Poliomyelitis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Poliomyelitis - Companies Involved in Therapeutics Development
Beijing Minhai Biotechnology Co Ltd
Beijing Tiantan Biological Products Co Ltd
Bharat Biotech Ltd
Biken Co Ltd
Biological E Ltd
Biological Mimetics Inc
Boryung Pharmaceutical Co Ltd
CanSino Biologics Inc
Cleveland BioLabs Inc
GlaxoSmithKline Plc
Grifols SA
Johnson & Johnson
KM Biologics Co Ltd
LG Chem Ltd
Micron Biomedical Inc
nolek LLC
Pacea Biotec Ltd
Sanofi Pasteur SA
Shantha Biotechnics Pvt Ltd
Univercells SA
Wuhan Institute of Biological Products Co Ltd
Poliomyelitis - Drug Profiles
(diphtheria + Haemophilus influenza [serotype B] + pertussis (acellular) + polio + tetanus) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diphtheria + haemophilus influenza [serotype B] + pertussis (acellular) + poliomyelitis + tetanus) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diphtheria + Haemophilus influenzae [serotype B] + hepatitis B + meningococcal [serotype C] + pertussis (whole cell) + poliomyelitis + tetanus) (heptavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diphtheria + haemophilus influenzae [serotype B] + hepatitis B + pertussis (whole cell) + poliomyelitis + tetanus) (hexavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diphtheria + haemophilus influenzae [serotype B] + hepatitis B + pertussis (whole cell) + poliomyelitis + tetanus) (hexavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Poliomyelitis - Dormant Projects
Poliomyelitis - Discontinued Products
Poliomyelitis - Product Development Milestones
Featured News & Press Releases
Apr 23, 2020: AJ Vaccines secures WHO Prequalification for polio vaccine Picovax
Apr 16, 2019: Sinovac announces positive results from Phase III trial Of a Sabin Strain-Based Ictivated Polio Vaccine (sIPV) published in the jourl of Infectiou
Jan 11, 2019: Univercells introduces breakthrough vaccine manufacturing platform
May 21, 2018: A single-injection vaccine for the polio virus
Apr 19, 2018: Sinovac Announces Prelimiry Results of Phase III Trial on sIPV
Dec 10, 2015: Sinovac Obtains Clinical Trial Approval for Sabin-IPV Candidate
May 11, 2011: Sanofi Pasteur Launches Pentaxim In Chi
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Poliomyelitis, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020


List of Tables


Number of Products under Development for Poliomyelitis, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Poliomyelitis - Pipeline by Beijing Minhai Biotechnology Co Ltd, H1 2020
Poliomyelitis - Pipeline by Beijing Tiantan Biological Products Co Ltd, H1 2020
Poliomyelitis - Pipeline by Bharat Biotech Ltd, H1 2020
Poliomyelitis - Pipeline by Biken Co Ltd, H1 2020
Poliomyelitis - Pipeline by Biological E Ltd, H1 2020
Poliomyelitis - Pipeline by Biological Mimetics Inc, H1 2020
Poliomyelitis - Pipeline by Boryung Pharmaceutical Co Ltd, H1 2020
Poliomyelitis - Pipeline by CanSino Biologics Inc, H1 2020
Poliomyelitis - Pipeline by Cleveland BioLabs Inc, H1 2020
Poliomyelitis - Pipeline by GlaxoSmithKline Plc, H1 2020
Poliomyelitis - Pipeline by Grifols SA, H1 2020
Poliomyelitis - Pipeline by Johnson & Johnson, H1 2020
Poliomyelitis - Pipeline by KM Biologics Co Ltd, H1 2020
Poliomyelitis - Pipeline by LG Chem Ltd, H1 2020
Poliomyelitis - Pipeline by Micron Biomedical Inc, H1 2020
Poliomyelitis - Pipeline by Nanolek LLC, H1 2020
Poliomyelitis - Pipeline by Panacea Biotec Ltd, H1 2020
Poliomyelitis - Pipeline by Sanofi Pasteur SA, H1 2020
Poliomyelitis - Pipeline by Shantha Biotechnics Pvt Ltd, H1 2020
Poliomyelitis - Pipeline by Univercells SA, H1 2020
Poliomyelitis - Pipeline by Wuhan Institute of Biological Products Co Ltd, H1 2020
Poliomyelitis - Dormant Projects, H1 2020
Poliomyelitis - Dormant Projects, H1 2020 (Contd..1), H1 2020
Poliomyelitis - Discontinued Products, H1 2020